2013 was a spectacular year for many reasons. Check out what the staff of the HCV Advocate voted as the top news items of 2013. We are all looking forward to 2014, and we would like to wish everyone a happy, healthy and prosperous 2014 and beyond.
Alan for the staff of HCV Advocate
1. HCV Advocate Newsletter: January 2014
In This Issue:
- HCV Advocate's Top News of 2013 —
Alan Franciscus, Editor-in-Chief
Read our annual top news stories – if we missed something let us know!
- HEALTHWISE: New Hepatitis C Drugs: Disappointment or Hope?— Lucinda K. Porter, RN
Read important information about Sovaldi and some pro's and con's about this newly approved medication.
- Snapshots—Lucinda K. Porter, RN
How long does hepatitis C live outside the body? You might be surprised by a new report recently released. Also, the cost effectiveness of interferon-free therapy and the effect of fructose on the liver are examined.
2. HBV Journal Review by Christine Kukka —In this month's column Chris reviews the following studies that will help you understand the complexities of hepatitis B, including
Amniocentesis Increases Risk of Hepatitis B Infection in
Tenofovir Alone Effective in Treating Adefovir-Resistant Hepatitis B
Another Study Confirms Increased Pancreatic Cancer Risk in People with Hepatitis B
Studies Uncover the Strengths and Weaknesses of the Antiviral Entecavir
Antiviral Telbivudine Appears to Protect Kidney Health
Experimental Treatment Would Help Immune System Attack HBV Infection
Study Shows Antiviral Treatment Helps Liver Function
Is There a New Normal for Healthy ALT Levels?
Obesity May Decrease Hepatitis B Vaccine Effectiveness, But Old Age Does Not
High Rates of Coinfections Underscore Need for Coordinated Care
More Evidence: Lamivudine Should Not Be Used in Pregnant Women
3 Social Security and Medicare Numbers for 2014 —Social Security and Medicare revise their benefits at the beginning of each year to update the programs for inflation with a Cost of Living Adjustment (COLA). Check out this article by Jacques Chambers, CLU, to find out what the figures are for 2014 and how they affect you
4 HCV Fact Sheets —We have updated most of our fact sheets and guides to include the latest information about Olysio (simeprevir) and Sovaldi (sofosbuvir). In addition we have added Easy C's and HCSP Fact Sheets about the newly approved medications.
5. Easy B Fact Sheets —We have updated all of the Easy B fact sheets in the Disease Management, Staying Healthy and Treatment series.
6. HCV Advocate News & Pipeline Blog!
Be sure to check out the latest clinical trial postings at the HCV Advocate News & Pipeline Blog. Just click on the links to the Drug Companies below the banner to see which drugs are in trials right now, where the trials are, and how to register for one.
Call 877-HELP-4-HEP line (877-435-7443). The helpline is open from 9:00am to 7:00pm Eastern Time.
and much, much more…..
Executive Director, Hepatitis C Support Project
Editor-in-Chief, HCV Advocate www.hcvadvocate.org
Editor-in-Chief, HBV Advocate www.hbvadvocate.org
**Questions and Comments: Questions and/or comments can be directed to email@example.com
**To receive the eblast in your email inbox simply send an e-mail to: firstname.lastname@example.org with nothing in the subject line and the following in the message body: subscribe emailalert. Make sure your email address is all lower case.